Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850]

Affiliations

• ¹ Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; Department of Internal Medicine and Medical Specialties (Di.M.I), University of Genoa, Genoa, Italy.
• ² Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
• ³ Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy; Oncology Department, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Milan, Italy.
• ⁴ Neurosurgery Unit, Head-Neck and NeuroScience Department, University Hospital of Udine, P.le S. Maria della Misericordia, 33100 Udine, Italy.
• ⁵ Department of Radiation Oncology, Sant'Andrea Hospital, University of Rome Sapienza, Via Grottarossa 1035, 00189 Rome, Italy.
• ⁶ Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neuro-Oncologie-Institut de Neurologie, F-75013 Paris, France.
• ⁷ Ivy Brain Tumor Center, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
• ⁸ Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerand.
• ⁹ Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
• ¹⁰ Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Electronic address: [email protected].